Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christel J Menet

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceutical Patent Analyst|October 8, 2014
Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseasesChristel J Menet
Progress in Medicinal Chemistry|February 7, 2013
Advances in the discovery of selective JAK inhibitorsChristel J Menet, Luc Van Rompaey, Raphaël Geney
Journal of the American Chemical Society|August 2, 2003
Stereospecific photochemical ring expansion of lithiated benzamidesJonathan Clayden, Faye E Knowles, Christel J Menet
Future Medicinal Chemistry|February 17, 2015
Progress toward JAK1-selective inhibitorsChristel J Menet, Oscar Mammoliti, Miriam López-Ramos
Chemical Communications (Cambridge, England)|July 18, 2002
Asymmetric deprotonation and dearomatising cyclisation of N-benzyl benzamides using chiral lithium amides: formal synthesis of (-)-kainic acidJonathan Clayden, Christel J Menet, Darren J Mansfield
Angewandte Chemie (International Ed. in English)|February 17, 2021
Development of Generic G Protein Peptidomimetics Able to Stabilize Active State G<sub>s</sub> Protein-Coupled Receptors for Application in Drug DiscoveryMorgane Mannes, Charlotte Martin, Sarah Triest, et al.
Journal of Medicinal Chemistry|November 5, 2014
Triazolopyridines as selective JAK1 inhibitors: from hit identification to GLPG0634Christel J Menet, Stephen R Fletcher, Guy Van Lommen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceutical Patent Analyst|October 8, 2014
Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseasesChristel J Menet
Progress in Medicinal Chemistry|February 7, 2013
Advances in the discovery of selective JAK inhibitorsChristel J Menet, Luc Van Rompaey, Raphaël Geney
Journal of the American Chemical Society|August 2, 2003
Stereospecific photochemical ring expansion of lithiated benzamidesJonathan Clayden, Faye E Knowles, Christel J Menet
Future Medicinal Chemistry|February 17, 2015
Progress toward JAK1-selective inhibitorsChristel J Menet, Oscar Mammoliti, Miriam López-Ramos
Chemical Communications (Cambridge, England)|July 18, 2002
Asymmetric deprotonation and dearomatising cyclisation of N-benzyl benzamides using chiral lithium amides: formal synthesis of (-)-kainic acidJonathan Clayden, Christel J Menet, Darren J Mansfield
Angewandte Chemie (International Ed. in English)|February 17, 2021
Development of Generic G Protein Peptidomimetics Able to Stabilize Active State G<sub>s</sub> Protein-Coupled Receptors for Application in Drug DiscoveryMorgane Mannes, Charlotte Martin, Sarah Triest, et al.
Journal of Medicinal Chemistry|November 5, 2014
Triazolopyridines as selective JAK1 inhibitors: from hit identification to GLPG0634Christel J Menet, Stephen R Fletcher, Guy Van Lommen, et al.
Pageof 1